Issue # 134: ŌURA Launches New Feature, Good Bud Raises $12 Million..

✨Hey there! You’re reading the free edition of the FemTech India newsletter — your go-to source for the latest in women’s health, industry updates, and opportunities to help you navigate what’s next in your journey.

ŌURA has launched two new AI-driven features, Meals and Glucose, to enhance its health tracking tools. By integrating biometric data with continuous glucose monitoring from Stelo by Dexcom, these features provide real-time insights into dietary choices and metabolic responses. They offer personalized guidance to improve metabolic health, which is crucial for preventing diseases like Type 2 diabetes and heart disease.

The Meals feature helps users analyze their meals by taking a photo, offering nutritional insights and focusing on macronutrient balance. The Glucose feature, integrated with Dexcom’s Stelo biosensor, provides continuous glucose tracking. Both features work with ŌURA’s AI-powered virtual health coach, Ōura Advisor, to offer personalized, data-backed advice on nutrition, sleep, and metabolic health.

After nearly 20 years in high-impact roles at Red Bull, Panasonic, and the IPL, Aashika Abraham found herself facing a new challenge: motherhood. Overwhelmed by the mental load, she realized many women felt the same. That insight sparked MAMMA-MIYA—an AI-powered app built to support busy moms with time, energy, and emotional management.

What started as a 5-woman WhatsApp group is now an Apple-recognized app, organically adopted in 127 countries, rated 4.8⭐ on the App Store, and helping thousands of moms manage their day, their energy, and their sanity.

“We spent two years just listening to moms before we wrote a single line of code,” she says. “Because balancing ambition and real life? That’s the hardest part. Everything else is figure-out-able.”

👉 Read her full story

• IPO-bound AI startup Fractal Analytics has submitted a proposal worth INR 150 crore (approximately $17.5 million) to the IndiaAI Mission.
• Breach Candy Hospital, a renowned healthcare facility in Mumbai, has launched its new modular operation theatres in collaboration with Dräger India, a global leader in medical technology. 
• GE HealthCare to Integrate AI-Enabled Solutions to its Radiation Oncology Portfolio.
• Sai Ganga Panakeia, an Indian healthtech company, has launched the next-generation version of its Ayurvedic-based wearable device, Docture-Poly in Hyderabad.

• Nutraceutical consumer startup The Good Bug has raised Rs 100 crore in new funding from Susquehanna Asia VC along with participation from existing investor Fireside Ventures.
• The Indian Institute of Information Technology (IIIT) Bhopal has been awarded four high-impact research projects under the Government of India’s flagship Partnerships for Accelerated Innovation and Research (PAIR) program. The program offers a cumulative research grant of INR 100 crores. 
• The Indian Institute of Technology Indore (IIT-I) is set to establish a Technology Translation Research Park (TTRP) to accelerate innovations in digital healthcare and strengthen India’s digital health ecosystem.

• PAQ Therapeutics, a Burlington, MA-based biotechnology company developing KRAS degraders, raised $39M in Series B funding.
• SafeHeal, a Paris, France- and Tampa, FL-based colorectal cancer surgery company, raised €35M in Series C equity funding.
• Zilia, a Quebec City, Canada-based medical technology company, raised an undisclosed amount in bridge funding.
• Zucara Therapeutics Inc., a Toronto, Canada-based diabetes life sciences company, raised $US5m in the second and final closing of its US$25m Series B financing.
• Danish medical device startup UVISA has secured 4.2 million DKK(approximately $600,000) in angel funding, bringing the total raised to 11.2 million DKK (€1.5M). The company also received approval to begin its first clinical trial for its light-based treatment for vaginal infections, specifically vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV).

In a first for India, Hempstreet has entered into a partnership with Thai Stick Company, one of the top cannabis industry players in Thailand, to take its pioneering dysmenorrhea formulation, among others, into the $1.3 billion Thailand market.

This marks a significant step in the creation of world leading IP in India in the global cannabis industry and the partnership aims to see jointly developed wellness and medical products in 2000 dispensaries accross Thailand by March 2026.

👉 Read the News

• Researchers at The Ohio State University have developed an insole that monitors walking, running, and standing patterns, with potential to provide early warnings for conditions such as Parkinson’s disease and diabetic foot ulcers.
• In a recent study published in the Journal of Neurophysiology, Mayo Clinic researchers have identified a new way to record and analyze brain activity during deep brain stimulation (DBS) surgery. 
• Synthetic chemicals called phthalates, found in consumer products such as food storage containers, shampoo, makeup, perfume and children’s toys, may have contributed to more than 10% of all global mortality from heart disease in 2018 among men and women ages 55 through 64, a new study found.
• Eating about a dozen servings of ultraprocessed food each day could more than double your risk of developing Parkinson’s disease, according to a new study.
• A study by researchers from the Kyung Hee University’s College of Medicine, South Korea, explored the link between shingles vaccine and cardiovascular diseases.  The study published in the European Heart Journal, aimed to provide evidence at a population level, allowing the team to look at the link between vaccination and 18 different types of cardiovascular disease. 
• When it comes to health, men seem to be facing serious challenges that often go unnoticed. A new study has revealed a troubling trend showing that men are more vulnerable to certain major health conditions compared to women. The research shows that compared to women, men are more likely to fall sick and die from three common conditions: hypertension, diabetes, and HIV/AIDS. 
• More than 1,000 measles cases have been reported in the United States in 2025, according to a CNN tally. This is only the second year cases have been this high since the disease was declared eliminated in the US a quarter-century ago, and a large multistate outbreak continues to grow, putting the nation on track for what could be the worst year since 2000.
• People who eat lots of ultra-processed foods (UPF) may be at greater risk of dying early, a study in eight countries including the UK and the US suggests.
• Processed meats, biscuits, fizzy drinks, ice cream and some breakfast cereals are examples of UPF, which are becoming increasingly common in diets worldwide.
• A New Treatment Is Transforming Prostate Cancer Care. The name, which combines “therapy” and “diagnostics,” hints at the treatment’s dual purpose: to identify cancer lesions and kill them on the spot with targeted radiotherapy.
• In a recent study, more than 150 women under age 75 filled out a questionnaire about their oral health based on the World Health Organization’s oral health survey. They were assessed for migraine, body pain, headaches, and abdominal (belly) pain. They also submitted saliva samples, which were analyzed for microbiota (the things living in the samples). The connection between oral health and pain was overwhelming.

• Novopor Advanced Science, a performance chemicals and material science CDMO, announced its acquisition of Pressure Chemical Company, an affiliate of the Minafin Group and a leading provider of high-pressure and specialty chemistry services. The financial terms of the transaction were not disclosed.
• Suven Pharmaceuticals has rebranded as Cohance Lifesciences. The move according to the company represents an evolution into a specialized, technology-driven global CDMO platform, purpose-built for the future of therapeutics.
• Aster DM Healthcare announced the signing of a lease agreement to establish its 4th multispecialty hospital in Bengaluru. This 430-bed state-of-the-art facility to come up in Sarjapur is set to revolutionize healthcare in the region with its comprehensive and specialized medical services.
• Astraveus SAS  announced that it has entered into a strategic partnership with The Netherlands Center for the Clinical Advancement of Stem Cell and Gene Therapies (NecstGen) to evaluate The Lakhesys Benchtop Cell Factory for the manufacturing of CAR-T therapies.

• The Maharashtra Government, in association with HLL Lifecare Limited, has launched 103 new “Aapla Dawakhana” clinics across Maharashtra.
• Union Minister Jitendra Singh on Sunday inaugurated North India’s first cutting-edge, technology-enabled cancer diagnostics laboratory, marking a significant leap in healthcare innovation.

📳 – Quick Reads: 

• Can vitamin D help prevent colorectal cancer? Experts have called for more studies to establish a meaningful and powerful link between vitamin D and lowering the risk of colorectal cancer (CRC).
• Should new moms exercise? New moms should try to accumulate 120 minutes weekly of aerobic and strength workouts, practice daily pelvic floor exercises, prioritize sleep, and reduce sitting

🎉Have news to share? Publish a press release on FemTech India to reach industry-leading executives, investors, and passionate individuals.

See you next Friday, friends 👋
Navneet

[Sign up here to never miss on the latest updates.]